Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNFSF15 anticorps

TNFSF15 Reactivité: Humain IHC (f) Hôte: Lapin Monoclonal VEGI-2052R unconjugated Recombinant Antibody
N° du produit ABIN6938630
  • Antigène Voir toutes TNFSF15 Anticorps
    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    • 88
    • 39
    • 17
    • 6
    • 5
    • 5
    • 5
    Humain
    Hôte
    • 66
    • 24
    • 1
    Lapin
    Clonalité
    • 63
    • 27
    • 2
    Monoclonal
    Conjugué
    • 48
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TNFSF15 est non-conjugé
    Application
    • 68
    • 30
    • 26
    • 25
    • 15
    • 13
    • 13
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    VEGI is an anti-angiogenic cytokine that belongs to tumor necrosis factor superfamily, member 15 (TNFSF15). This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of VEGI has been reported as a marker of poor prognosis in breast cancer.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant full-length human VEGI protein
    Clone
    VEGI-2052R
    Isotype
    IgG
    Top Product
    Discover our top product TNFSF15 Anticorps primaire
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Endothelial cells. Colon, intestine, placenta, lung, liver, kidney, pancreas, spleen or prostate.

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
    Autre désignation
    TNFSF15 (TNFSF15 Produits)
    Synonymes
    anticorps TTPAL, anticorps TL1, anticorps TL1A, anticorps VEGI, anticorps VEGI192A, anticorps Tl1, anticorps Tl1a, anticorps Vegi, anticorps tumor necrosis factor superfamily member 15, anticorps TNF superfamily member 15, anticorps tumor necrosis factor (ligand) superfamily, member 15, anticorps TNFSF15, anticorps Tnfsf15
    Sujet
    TNF ligand-related molecule 1 (TL1A), Tumor necrosis factor (ligand) superfamily member 15 (TNFSF15), Vascular endothelial growth inhibitor 192a, Vascular endothelial growth inhibitor (VEGI), VEGI192A,TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor)
    Cellular localisation: Secreted and Cell Surface
    Poids moléculaire
    22kDa
    ID gène
    9966, 241382
    UniProt
    O95150
    Pathways
    Positive Regulation of Endopeptidase Activity, Autophagy
Vous êtes ici:
Support technique